Recalls / Active ingredient / Topiramate
Topiramate
6 FDA drug recalls involving the active ingredient “Topiramate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-12-08 | Class III | Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceutica | Azurity Pharmaceuticals, Inc. |
| 2021-10-25 | Class III | Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Are | UNICHEM PHARMACEUTICALS USA INC |
| 2021-03-15 | Class II | Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharm | Cardinal Health Inc. |
| 2016-07-12 | Class II | Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Cata | Supernus Pharmaceuticals, Inc. |
| 2014-09-15 | Class II | TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India | Zydus Pharmaceuticals USA Inc |
| 2013-04-05 | Class III | Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark G | Glenmark Generics Inc., USA |